Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to test the effectiveness and tolerability of Niaspan®
to improve the levels of blood fats ("good" and "bad" cholesterol and triglyceride levels) in
people who have kidney damage due to diabetes. A secondary goal is to test whether Niaspan®
slows down further development of kidney damage.